+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Treatment of Crohns disease with infliximab An initial community practice experience



Treatment of Crohns disease with infliximab An initial community practice experience



Gastroenterology 118(4 Suppl 2 Part 1): AGA A567




(PDF emailed within 1 workday: $29.90)

Accession: 035980386

Download citation: RISBibTeXText


Related references

Infliximab in Crohns disease An office-based gastroenterologists community experience. American Journal of Gastroenterology 95(9): 2495, 2000

The safety profile of infliximab for crohns disease in clinical practice the mayo clinic experience in 500 patients. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No 64, 2003

Infliximab therapy for Crohns disease The Crohns and colitis center of New Jersey experience. Gastroenterology 118(4 Suppl 2 Part 2): AGA A1334, 2000

Preliminary clinical experience with Infliximab in the treatment of refractory and fistulizing Crohns disease. Gastroenterology 118(4 Suppl 2 Part 1): AGA A565, 2000

Infliximab treatment for Crohns disease treated with elemental diet The Tokyo experience. American Journal of Gastroenterology 98(9 Supplement): S252-S253, 2003

The Reasons for Discontinuation of Infliximab Treatment in Patients with Crohns Disease A Review of Practice at NHS Teaching Hospital. 2012

Effects of antibodies to infliximab on safety and efficacy of infliximab treatment in patients with Crohns disease. Gastroenterology 122(4 Suppl 1): A 613-A 614, 2002

Effect of antibodies to infliximab on infusion reaction and clinical response in patients with fistulizing crohns disease receiving maintenance treatment with infliximab. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No M1598, 2003

Infliximab for Crohns Disease One units experience. Gut 50(Supplement 2): A76, 2002

Complete bowel obstruction following initial response to infliximab therapy for Crohns disease A series of a newly described complication. Gastroenterology 118(4 Suppl 2 Part 1): AGA A569, 2000

Collaborative experience of open-label infliximab in refractory pediatric Crohns disease. JPGN 31(Supplement 2): S227, 2000

Treatment of cutaneous Crohns disease with infliximab. American Journal of Gastroenterology 98(9 Supplement): S250-S251, 2003

Crohns disease, infliximab treatment and IgA nephropathy. American Journal of Gastroenterology 98(9 Supplement): S199, 2003

Infliximab for treatment of perineal metastatic Crohns disease. Gastroenterology 118(4 Suppl 2 Part 1): AGA A588, 2000

Successful treatment of esophageal Crohns disease with infliximab. American Journal of Gastroenterology 95(9): 2419, 2000